Systematic identification of genomic markers of drug sensitivity in cancer cellsMathew J. Garnett, Daniel A. Haber, Elena J. Edelman et al.|Nature|2012Cited by 2.6k
SWI/SNF Chromatin Remodeling and Human MalignanciesJulien Masliah‐Planchon, Olivier Delattre|Annual Review of Pathology Mechanisms of Disease|2014Cited by 327
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatelliteThomas G. P. Grünewald, Olivier Delattre, Carlo Lucchesi et al.|Nature Genetics|2015Cited by 209
Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Clinical Cancer Research|2014Cited by 99
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomesJulian Musa, Thomas G. P. Grünewald, Florencia Cidre‐Aranaz et al.|Nature Communications|2019Cited by 72